Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 2,293-2,304 of 5,650
Behavioral study icon
RecruitingNCT07101094

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Multiple locations, including Orange
SchizophreniaBehavioralOver 18 Years
Countries
United States
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
Drug study icon
RecruitingNCT07184619

Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia

This study is comparing Evenamide 15 mg bid with placebo for people with Treatment-resistant Schizophrenia. Participants receive Evenamide 15 mg bid or placebo and complete study visits and assessments.

Multiple locations, including Los Angeles
SchizophreniaDrugOver 18 Years
Countries
United States, India
Sponsor
Newron Pharmaceuticals SPA
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.